Harvard bioscience reports q3 adjusted earnings per share of $0.04

Harvard bioscience announces third quarter financial results.q3 adjusted earnings per share $0.04.q3 loss per share $0.07.sees fy 2019 revenue $116 million to $118 million.q3 revenue $27.4 million versus refinitiv ibes estimate of $28.7 million.q3 earnings per share estimate $0.05 -- refinitiv ibes data.as of september 30, 2019, cash was $6.8 million and total debt was $54.3 million.

HBIO Ratings Summary

HBIO Quant Ranking